ganciclovir
PolandDrugs containing this active substance
-
The medicine is intended for the treatment of diseases caused by cytomegalovirus (CMV) in immunocompromised adults and adolescents (over 12 years of age). It is also used to prevent infections with this virus following organ transplantation or during chemotherapy in adults and children.
Form: powder for preparation of concentrate for infusion solution
Active substance Dosage ganciclovir 500 mg ATC: J05AB06
Manufacturer: CHEPLAPHARM Arzneimittel GmbH
-
The medicine is intended for the treatment of diseases caused by cytomegalovirus (CMV) in immunocompromised adults and adolescents (over 12 years of age). It is also used to prevent infections with this virus after organ transplantation or during chemotherapy in adults and children.
Form: powder for preparation of concentrate for infusion solution
Active substance Dosage ganciclovir 500 mg ATC: J05AB06
Manufacturer: Laboratori Fundació Dau Reig Jofre S.A.
-
It is used to treat certain superficial viral infections of the eye (cornea).
Form: gel, ophthalmic
Active substance Dosage ganciclovir 1.5 mg/g ATC: S01AD09
Manufacturer: Laboratoires THÉA
-
It is used to treat certain superficial and viral eye (corneal) infections.
Form: gel, ophthalmic
Active substance Dosage ganciclovir 1.5 mg/g ATC: S01AD09
Manufacturer: Laboratoires THEA
-
It is used to treat certain superficial viral infections of the eye (cornea).
Form: gel, ophthalmic
Active substance Dosage ganciclovir 1.5 mg/g ATC: S01AD09
Manufacturer: Laboratoires THEA
-
It is used to treat certain superficial and viral eye (corneal) infections.
Form: gel, ophthalmic
Active substance Dosage ganciclovir 1.5 mg/g ATC: S01AD09
Manufacturer: Laboratoires THEA
-
It is used to treat certain superficial and viral eye (corneal) infections.
Form: gel, ophthalmic
Active substance Dosage ganciclovir 1.5 mg/g ATC: S01AD09
Manufacturer: Laboratoires THÉA